Larvol Delta - Viracta-Therapeutics-to-Present-Topline-Nanaval-Results-from-Stage-1-of-the-NAVAL1-Trial-at-the-2024-Annual-Congress-of-The-Hematology-Society-of-Taiwan

Valcyte (valganciclovir) - Roche, Mitsubishi Tanabe

nanatinostat (VRx-3996) - Viracta Therap

https://www.globenewswire.com/news-release/2024/04/01/2855187/0/en/Viracta-Therapeutics-to-Present-Topline-Nana-val-Results-from-Stage-1-of-the-NAVAL-1-Trial-at-the-2024-Annual-Congress-of-The-Hematology-Society-of-Taiwan.html

Apr 1, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next